Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy: genes and variants
Explore variant evidence for Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy across 1 analyzed protein (OPA1). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 6 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
OPA1: Dynamin-like GTPase OPA1, mitochondrial
A mitochondrial dynamin-related GTPase that fuses inner mitochondrial membranes and shapes cristae. By maintaining mitochondrial architecture and respiratory-chain function, it supports cell energy production, and OPA1 variants cause inherited optic-atrophy syndromes.
10 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in OPA1 have source records linked to Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| OPA1 D438G | 438 | Dynamin-type G | Pathogenic / likely pathogenic (★★) |
| OPA1 K204R | 204 | Mitochondrial intermembrane | Pathogenic / likely pathogenic (★★) |
| OPA1 F552L | 552 | Dynamin-type G | Pathogenic / likely pathogenic (★) |
| OPA1 S318C | 318 | Dynamin-type G | Pathogenic / likely pathogenic (★) |
| OPA1 C551Y | 551 | Dynamin-type G | Pathogenic / likely pathogenic |
| OPA1 Y637C | 637 | Stalk region | Pathogenic / likely pathogenic |
| OPA1 S269P | 269 | Mitochondrial intermembrane | Pathogenic / likely pathogenic |
| OPA1 E519K | 519 | Dynamin-type G | Pathogenic / likely pathogenic |
| OPA1 Y582C | 582 | Mitochondrial intermembrane | Pathogenic / likely pathogenic |
| OPA1 V910D | 910 | Coiled coil | Pathogenic / likely pathogenic |
Which prediction tools work for Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 88 out of 100
- AlphaMissense: 88 out of 100
- SIFT: 87 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 83 out of 100
- MetaLR: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal dominant optic atrophy classic form also has ClinVar records linked to OPA1 variants; they fall mostly in different places as the Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy variants (13 pathogenic / likely pathogenic).
- Optic atrophy also has ClinVar records linked to OPA1 variants; they fall mostly in different places as the Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy variants (7 pathogenic / likely pathogenic).
Diseases related to Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy
- Auditory neuropathy, also linked to OPA1
- Autosomal dominant optic atrophy classic form, also linked to OPA1
- Optic atrophy, also linked to OPA1
- Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type), also linked to OPA1
Frequently asked questions
Which genes have records linked to Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy?
This view contains 1 analyzed proteins: OPA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 6 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 33 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center